AB

Alkesh Bhavrilal Chopda

Active Director Director DIN 05251130
DIN 05251130 First appointment Mar 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Mar 2014
Shareholding value •••• Premium profile

About Alkesh Bhavrilal Chopda

Data last updated:

Alkesh Bhavrilal Chopda is a Director at Magnum Pharma And Diagnostic Services Private Limited (since 2014), Director at Eternal Lifesciences Private Limited (since 2020) and Director at Publikcity Media Private Limited (since 2020), and holds 2 more current directorships. The companies operate in Pharma, Trading and Business Services. The 5 current companies with reported revenue have a combined latest revenue of ₹10.35 Cr; the largest is Magnum Pharma And Diagnostic Services Private Limited at ₹9.82 Cr (FY 2025).

DIN 05251130
Primary Designation Director
Industry Pharma
First Appointment 18 Mar 2014
Oldest Company Age 12 yrs
Largest company Magnum Pharma And Diagnostic Services Private Limited · ₹9.82 Cr (FY 2025)
Combined revenue ₹10.35 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Mar 20142014₹9.82 Cr (FY 2025)Active
Eternal Lifesciences Private Limited U51909MH2020PTC343005
Director31 Jul 20202020₹38.8 Lakh (FY 2024)Active
Publikcity Media Private Limited U74999MH2020PTC351225
Director03 Dec 20202020₹10.3 Lakh (FY 2024)Active
Medezzy Pharmacy Private Limited U24110MH2020PTC348784
Nominee Director26 Oct 20202020₹1.7 Lakh (FY 2024)Active
Chai Tapri Private Limited U74999MH2016PTC286532
Director04 Oct 20162016₹1.5 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Medezzy Pharmacy Private Limited
Magnum Pharma And Diagnostic Services Private Limited
Eternal Lifesciences Private Limited
Chai Tapri Private Limited
Premium access

Shareholding and investment profile for Alkesh Bhavrilal Chopda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alkesh Bhavrilal Chopda

Alkesh Bhavrilal Chopda currently holds 5 directorships: Magnum Pharma And Diagnostic Services Private Limited (Director, since 18 Mar 2014, revenue ₹9.82 Cr (FY 2025)); Eternal Lifesciences Private Limited (Director, since 31 Jul 2020, revenue ₹38.8 Lakh (FY 2024)); Publikcity Media Private Limited (Director, since 03 Dec 2020, revenue ₹10.3 Lakh (FY 2024)); Medezzy Pharmacy Private Limited (Nominee Director, since 26 Oct 2020, revenue ₹1.7 Lakh (FY 2024)); Chai Tapri Private Limited (Director, since 04 Oct 2016, revenue ₹1.5 Lakh (FY 2024)).

Alkesh Bhavrilal Chopda was first appointed on 18 Mar 2014 as Director at Magnum Pharma And Diagnostic Services Private Limited. The most recent appointment on record is 03 Dec 2020 at Publikcity Media Private Limited.

The 5 current companies of Alkesh Bhavrilal Chopda that report revenue have a combined latest revenue of ₹10.35 Cr: Magnum Pharma And Diagnostic Services Private Limited ₹9.82 Cr (FY 2025); Eternal Lifesciences Private Limited ₹38.8 Lakh (FY 2024); Publikcity Media Private Limited ₹10.3 Lakh (FY 2024); Medezzy Pharmacy Private Limited ₹1.7 Lakh (FY 2024); Chai Tapri Private Limited ₹1.5 Lakh (FY 2024).

The current boards of Alkesh Bhavrilal Chopda's companies include Rashmi Manoj Chopda (Magnum Pharma And Diagnostic Services Private Limited), Sonali Alkesh Chopda (Magnum Pharma And Diagnostic Services Private Limited), Manoj Chopda Bhavrilal (Eternal Lifesciences Private Limited), Bhoomi Alkesh Chopda (Publikcity Media Private Limited), Diya Alkesh Chopda (Publikcity Media Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available